Document is current
Any future updates will be listed below
-
Authors
Pan, Youdong
Liu, Luzheng
Tian, Tian
Zhao, Jingxia
Park, Chang Ook https://orcid.org/0000-0003-3856-1201
Lofftus, Serena Y.
Stingley, Claire A.
Yan, Yu
Mei, Shenglin
Liu, Xing
Kupper, Thomas S. https://orcid.org/0000-0002-4229-2916
- License Information
-
More Information
Article History
Received: 27 May 2020
Accepted: 10 November 2020
First Online: 4 January 2021
Competing interests
: T.S.K. and L.L. are inventors on a patent relevant to this study (US8691502B2). The patent is now owned by Pellis Therapeutics, a biotech company, in which T.S.K. and L.L. have equity. T.S.K. has received supplemental funding from the NIAID to study MVA s.s immunization with constructs encoding SARS CoV2 proteins, including Spike (R01 AI127654).
